{"symbol": "XXII", "companyName": "22nd Century Group Inc.", "exchange": "NYSE American", "industry": "Biotechnology", "website": "http://www.xxiicentury.com", "description": "22nd Century Group Inc is a plant biotechnology company. It is focused on technology that allow to increase or decrease the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants.", "CEO": "Henry Sicignano", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}